For informational purposes only — not investment advice

← Back to signals

LEN

CONGRESS BUY

LENNAR CORPORATION

Research: Finviz ↗·Perplexity ↗

No convergence signal this quarter — shown because tracked funds have filed 13D/G on this stock.

Days to cover (short int.)
6.5d-1.3%
as of 2026-07-31

News Summary

Negative

Lennar reported Q2 2026 earnings that missed expectations and triggered analyst downgrades across the board, with consensus EPS estimates for 2026 cut by 22% (from $8.84 to $6.91) due to persistent margin compression from incentives and affordability pressures in a weakening housing market. Management restructuring in June elevated two Area Presidents to COO and EVP roles, while guidance for 2026 home deliveries remains steady at 85,000 units but at significantly lower profitability margins (15%–16% gross margin vs. 17%+ historical levels).

Red flags

  • Q2 2026 earnings miss triggered negative market reaction; stock down 28.6% over six months and near 52-week lows
  • Gross margin compressed to 15.2%–17% range with analyst expectations for further deterioration; 2026 net income forecast to shrink 21% vs. 7.8% industry average
  • Consensus price target slashed from $127 to $115 with multiple downgrades (Keefe Bruyette to Underperform with $85 PT, RBC to $85, BTIG Sell at $73)
  • 2026 revenue guidance reduced from $35.0B to $33.7B; EPS estimates cut 8%–12% for 2026–2027 across multiple analysts
  • Ongoing legal exposure: Seminole Tribe lawsuit over defective homes on tribal reservations
  • High entry-level exposure in demand-constrained market with 'choppy' conditions per CEO; incentive levels elevated for three consecutive years

Fund 13D/13G Filings (1)

Tracked funds' beneficial-ownership filings on this stock — disclosed within days of a position change, fresher than the quarterly 13F. Since Filing compares the stock to SPY from the filing date (shown for filings within the last 90 days).

FundForm∆ Shares% of ClassSince FilingFiledSrc
Berkshire HathawaySC 13GNEW6.2%
+0.1% vs SPY
-1.6% abs
2026-08-14

Congressional Trading

MemberChamberStateTypeAmount RangeTransaction DateFiledSrc
Alan ArmstrongsenateBUY$1,001 - $15,0002026-03-272026-07-21

Periodic Transaction Reports filed under the STOCK Act. Amounts are disclosed as ranges, not exact dollar figures.